Home › Funds › Paradigm Biocapital Advisors LP › MBX

Paradigm Biocapital Advisors LP position in MBX

MBX BIOSCIENCES INC COM · Health Care

Paradigm Biocapital Advisors LP reported holding 2,508,015 shares of MBX (MBX BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$138.4M, representing 2.59% of its reported portfolio and ranking #14 among its reported holdings. Paradigm Biocapital Advisors LP first reported this position in Q2 2026.

Latest position (Q2 2026)2.51M sh
Reported value held$138.44M
Portfolio Weight2.59%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Paradigm Biocapital Advisors LP's MBX position evolved

Paradigm Biocapital Advisors LP first disclosed a stake in MBX in Q2 2026 at 2,508,015 shares (US$138.4M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 2.51M $138.44M New

About MBX and 13F data

MBX (MBX BIOSCIENCES INC COM) is a Health Care company. 73 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$367.2M), NEA Management Company, LLC (US$199.5M), ORBIMED ADVISORS LLC (US$189.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MBX

All MBX fund holders →

FAQ

How long has Paradigm Biocapital Advisors LP held MBX?

Paradigm Biocapital Advisors LP has disclosed MBX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Paradigm Biocapital Advisors LP's current position in MBX?

As of Q2 2026, Paradigm Biocapital Advisors LP holds 2.51M shares of MBX (MBX BIOSCIENCES INC COM), valued at $138.44M, representing 2.59% of its reported portfolio and ranking #14.

Has Paradigm Biocapital Advisors LP been buying or selling MBX?

In the latest 13F filing (Q2 2026), Paradigm Biocapital Advisors LP newly opened its position in MBX.

Which other funds hold MBX?

Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., NEA Management Company, LLC, ORBIMED ADVISORS LLC, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.